Condition
MNGIE
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Enrolling By Invitation1
Recruiting1
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT01803906Enrolling By Invitation
Tissue Sample Study for Mitochondrial Disorders
NCT05554835Recruiting
Global Registry and Natural History Study for Mitochondrial Disorders
NCT05658822UnknownPrimary
Digestive Dysmotility in Mitochondrial Neurogastrointestinal Encephalomyopathy
Showing all 3 trials